Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Semnur Pharmaceuticals, Denali Capital Acquisition Sign LoI For Proposed Business Combination, Which Provides For Pre-Transaction Equity Value Of Semnur Of Up To $2.0B

Author: Benzinga Newsdesk | July 02, 2024 05:18pm
Scilex is expected to be the majority holder of the combined company following completion of the proposed business combination.

Posted In: DECA SCLX